Robert Gabbay, MD, PhD, ADA Chief Scientific and Medical Officer, outlines how the COVID-19 pandemic has served as an accelerant of change for the ADA and the health care community.
News Updates from the 83rd Scientific Sessions
Robert Gabbay, MD, PhD, ADA Chief Scientific and Medical Officer, outlines how the COVID-19 pandemic has served as an accelerant of change for the ADA and the health care community.
